indazoles has been researched along with Connective and Soft Tissue Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, D; Jones, RL; Katz, D; Loggers, ET; Pollack, SM; Rodler, ET | 1 |
| Bernabeu, D; Blay, JY; Brenca, M; Brich, S; Casali, PG; Castelli, C; Collini, P; Cruz, J; Dagrada, GP; de Alava, E; Dumont, S; Ferrari, S; Frezza, AM; Grignani, G; Gutierrez, A; Hindi, N; Italiano, A; Karanian, M; LeCesne, A; Lopez-Pousa, A; Maestro, R; Martin-Broto, J; Morosi, C; Palmerini, E; Penel, N; Racanelli, D; Redondo, A; Stacchiotti, S; Vallacchi, V; Vaz Salgado, MA | 1 |
1 trial(s) available for indazoles and Connective and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chondrosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Male; Middle Aged; Neoplasm Staging; Neoplasms, Connective and Soft Tissue; Pyrimidines; Retrospective Studies; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome | 2019 |
1 other study(ies) available for indazoles and Connective and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chondrosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasms, Connective and Soft Tissue; Pyrimidines; Ramucirumab; Retrospective Studies; Sulfonamides; Treatment Outcome | 2017 |